| 000 | 00965 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517201758.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1827-1855 | ||
| 024 | 7 |
_a10.23736/S0390-5616.18.04081-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArif, Sajad H | |
| 245 | 0 | 0 |
_aWITHDRAWAL: Significant effect of anti-tyrosine kinase inhibitor (Gefitinib) on overall survival of the Glioblastoma (GBM) patients in the backdrop of mutational status of EGFR and PTEN genes. _h[electronic resource] |
| 260 |
_bJournal of neurosurgical sciences _c02 2018 |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aPandith, Arshad A | |
| 700 | 1 | _aTabasum, Rehana | |
| 700 | 1 | _aRamzan, Altaf U | |
| 700 | 1 | _aSingh, Sarabjeet | |
| 700 | 1 | _aSiddiqi, Mushtaq A | |
| 700 | 1 | _aBhat, Abdul R | |
| 773 | 0 | _tJournal of neurosurgical sciences | |
| 856 | 4 | 0 |
_uhttps://doi.org/10.23736/S0390-5616.18.04081-X _zAvailable from publisher's website |
| 999 |
_c28086886 _d28086886 |
||